Bullish Moving Average Cross by Rubicon Technology (RBCN)
Rubicon Technology (NASDAQ:RBCN) shares have crossed bullishly above their 10-day moving average of $9.53 on a volume of 182K shares. This may provide short-term investors a chance for a long position, as such a crossover often suggests higher prices in the near term.
Rubicon Technology, Inc. develops, manufactures, and sells monocrystalline sapphire and other crystalline products. The Company's products are used in Light-Emitting Diodes ("LEDs"), radio frequency integrated circuits ("RFICs"), blue laser diodes, and optoelectronics and other optical applications.
In the past 52 weeks, shares of Rubicon Technology have traded between a low of $8.23 and a high of $29.79 and are now at $9.72, which is 18% above that low price. The 200-day and 50-day moving averages have moved 2.04% lower and 0.34% lower over the past week, respectively.
There is potential upside of 23.9% for shares of Rubicon Technology based on a current price of $9.72 and an average consensus analyst price target of $12.04. The stock should find initial resistance at its 50-day moving average (MA) of $10.04 and further resistance at its 200-day MA of $16.28.
Blue Laser Diodes - News
Products include laser diode modules with wavelengths from 263nm to 13900nm that span the UV, Blue, Green, Red and Infrared range, temperature stabilized modules, lasers with beam circularization, and CW, pulsed, and modulated lasers.
The Company's products are used in Light-Emitting Diodes ("LEDs"), radio frequency integrated circuits ("RFICs"), blue laser diodes, and optoelectronics and other optical applications. In the past 52 weeks, shares of Rubicon Technology have traded
Diode laser therapy targets the middle layer of the dermis, destroying sebaceous glands without damaging the top layer (the epidermis) of the skin. Pain medication is usually needed prior to treatment and redness and swelling may occur.
One of the first home laser devices to be studied, the Tria diode laser, showed mean hair reductions of 60% at 1 month, 41% at 6 months, and 33% at 12 months after three home treatments in 77 appropriate users (Lasers Surg. Med. 2007;39:476-93).
The Company's products are used in Light-Emitting Diodes ("LEDs"), radio frequency integrated circuits ("RFICs"), blue laser diodes, and optoelectronics and other optical applications. Rubicon Technology (NASDAQ:RBCN) has potential upside of 26.0%
